Cohort AI Platform
AI-powered population health and healthcare analytics platform
Platform · Cloud SaaSCompany source
Company profile
About Cohort
Cohort is a company operating in the population health and healthcare analytics space. Based on their domain and category classification, the company likely provides AI-powered solutions for analyzing patient populations, identifying care gaps, and supporting value-based care initiatives. However, the specific details of their technology platform, target customers, and product offerings could not be determined from the available website content. The company appears to be positioned in the growing market of healthcare data analytics and population health management, which typically serves health systems, payers, and accountable care organizations seeking to improve patient outcomes while managing costs.
Company description Cohort official website
Primary marketPopulation Health & Healthcare Analytics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Cohort?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
No customer types are currently listed.
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Association Between Changes in Serum N-Terminal Pro B-Type Natriuretic Peptide Levels and All-Cause and Cause-Specific Mortality - The Hisayama Study.Circulation journal : official journal of the Japanese Circulation Society · Sep 2, 2026
Robust inference and correlates from genetic associations with personality.Nature · Sep 2, 2026
Nutrition provision across acute hospitalization in adult patients receiving extracorporeal membrane oxygenation: A prospective multicenter observational, registry-embedded study.Nutrition (Burbank, Los Angeles County, Calif.) · Sep 1, 2026
IMRT planning quality under a single full-time radiation oncologist supported by structured remote peer review and planning assistance versus the two-oncologist standard: the REMOTE-IMRT prospective, pair-matched, multi-institutional trial.Japanese journal of radiology · Aug 30, 2026
Stent Retriever Thrombectomy in Patients With Myocardial Infarction The Open-label, Multicenter NATURE Superiority trial.Journal of the American College of Cardiology · Aug 29, 2026
Multistrain probiotics modulate tau pathology and preserve visuospatial cognition in early cognitive impairment: A double-blind, randomized, placebo-controlled trial.Journal of Alzheimer's disease : JAD · Aug 28, 2026
Clinical validation
Clinical-trial records
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast MalignanciesNCT07211178 · Mentioned · RECRUITING
Toxin Exposure and Immune Dysregulation in Non-Hodgkin LymphomaNCT07652580 · Mentioned · RECRUITING
A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)NCT05776472 · Mentioned · ACTIVE NOT RECRUITING
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingNCT04981119 · Mentioned · RECRUITING
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation TherapyNCT07507422 · Mentioned · RECRUITING
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNCT06172296 · Mentioned · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Cohort
Recent articles published on Cohort's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Population Health & Healthcare Analytics
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.